drug · small molecule
patient view →giredestrant
pre_registrationupdated 2mo agoby Genentech Inc🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
indications
indications
Breast Cancer
targets
Estrogen receptor
all catalysts(0)
nothing on the calendar yet
News(2)
- Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs<p>On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.</p>biopharma_dive · 2mo ago
- Roche says its investigational breast cancer pill could outsell HerceptinRoche still has high sales hopes for its breast cancer pill giredestrant despite the drug’s failure in a first-line trial earlier this year. CEO Thomas Schinecker said Thursday that the drug coul…endpoints · 2mo ago
comments(0)
5-min edit window · permanent after that